Bismuth Quadruple Therapy Prescription for H. pylori-Related Peptic Ulcer Disease
For this established patient with H. pylori-related peptic ulcer disease, prescribe bismuth quadruple therapy for 14 days consisting of: esomeprazole 40 mg twice daily, bismuth subsalicylate 262 mg (two tablets) four times daily, metronidazole 500 mg four times daily, and tetracycline 500 mg four times daily. 1, 2
Complete Prescription (All Medications on Same Rx)
Patient Name: [PATIENT]
Date of Birth: [DATE]
1. Esomeprazole 40 mg capsules
- Dose: Take ONE capsule by mouth TWICE daily
- Timing: 30 minutes before breakfast and 30 minutes before dinner
- Duration: 14 days
- Quantity: 28 capsules
- Refills: 0
2. Bismuth subsalicylate 262 mg tablets
- Dose: Take TWO tablets by mouth FOUR times daily
- Timing: 30 minutes before meals (breakfast, lunch, dinner) and at bedtime
- Duration: 14 days
- Quantity: 112 tablets
- Refills: 0
3. Metronidazole 500 mg tablets
- Dose: Take ONE tablet by mouth FOUR times daily
- Timing: 30 minutes after meals (breakfast, lunch, dinner) and at bedtime
- Duration: 14 days
- Quantity: 56 tablets
- Refills: 0
4. Tetracycline hydrochloride 500 mg capsules
- Dose: Take ONE capsule by mouth FOUR times daily
- Timing: 30 minutes after meals (breakfast, lunch, dinner) and at bedtime
- Duration: 14 days
- Quantity: 56 capsules
- Refills: 0
Rationale and Optimization
Bismuth quadruple therapy achieves 80–90% eradication rates even in regions with high clarithromycin and metronidazole resistance (>15–20%), making it the preferred first-line empiric regimen in North America. 1, 2
Esomeprazole 40 mg twice daily is strongly preferred over standard-dose PPIs because it increases cure rates by 8–12% through superior acid suppression. 1, 2, 3
The 14-day duration is mandatory; extending therapy from 7 to 14 days improves eradication success by approximately 5%. 1, 2, 3
Bismuth has no documented bacterial resistance, and its synergistic effect overcomes metronidazole resistance in vitro, preserving regimen efficacy even against resistant strains. 1, 2
Critical Patient Instructions
Take the PPI (esomeprazole) 30 minutes before meals on an empty stomach without concomitant antacids to maximize absorption and acid suppression. 1, 2, 3
Complete the entire 14-day course even if symptoms improve earlier; incomplete treatment increases resistance development and treatment failure. 1, 2
Expect diarrhea in approximately 21–41% of patients during the first week due to disruption of normal gut microbiota; this does not indicate treatment failure. 2
Avoid alcohol during metronidazole therapy to prevent disulfiram-like reactions. 1
Tetracycline may cause photosensitivity; advise sun protection during treatment. 1
Confirmation of Eradication
Perform a urea breath test or monoclonal stool antigen test at least 4 weeks after completing therapy to confirm eradication. 1, 2
Discontinue the PPI at least 2 weeks (preferably 7–14 days) before testing to avoid false-negative results. 1, 2
Never use serology for test-of-cure because antibodies persist long after successful eradication. 1, 2
Common Pitfalls to Avoid
Do not substitute pantoprazole for esomeprazole; 40 mg pantoprazole provides acid suppression equivalent to only 9 mg omeprazole, significantly reducing efficacy. 1, 3, 4
Do not shorten therapy below 14 days; this reduces eradication success by approximately 5%. 1, 2, 3
Do not substitute doxycycline for tetracycline; tetracycline 500 mg four times daily is required for optimal efficacy. 1, 2
Smoking roughly doubles the odds of treatment failure (OR ≈ 1.95); strongly advise cessation during therapy. 2